Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline - PubMed (original) (raw)

. 2021 Jul;69(7):1826-1835.

doi: 10.1111/jgs.17206. Epub 2021 May 5.

Affiliations

Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline

Michal S Beeri et al. J Am Geriatr Soc. 2021 Jul.

Abstract

Objective: We examined whether sarcopenia is associated with the occurrence of late-life cognitive impairment.

Methods: Nondemented older adults (N = 1175) underwent annual testing with 17 cognitive tests summarized as a global cognitive score. A composite sarcopenia score was constructed based on muscle mass measured with bioelectrical impedance and muscle function based on grip strength. Cox proportional hazard models were employed to examine associations of sarcopenia with incident Alzheimer's dementia (AD) and incident mild cognitive impairment (MCI). Linear mixed-effect models determined the association of sarcopenia with cognitive decline. All models controlled for age, sex, education, race, and height squared.

Results: Average follow-up was 5.6 years. More severe sarcopenia at baseline was associated with a higher risk of incident AD (hazard ratio [HR], 1.50 [95% confidence interval 1.20-1.86]; p < 0.001) and of MCI (1.21 [1.01-1.45]; 0.04) and a faster rate of cognitive decline (estimate = -0.013; p = 0.01). Analyses of the individual components of sarcopenia showed that muscle function was associated with incident AD, incident MCI, and cognitive decline with and without a term for lean muscle mass in the model. In contrast, lean muscle mass was not associated with incident cognitive impairment or cognitive decline when a term for muscle function was included in the model.

Conclusions: Poor muscle function, but not reduced lean muscle mass, drives the association of sarcopenia with late-life cognitive impairment. Further work is needed to identify features of muscle structure, which may increase the specificity of sarcopenia for identifying older adults at risk for late-life cognitive impairment.

Keywords: Alzheimer's disease; cognitive decline; mild cognitive impairment; sarcopenia.

© 2021 The American Geriatrics Society.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors report no conflict of interest

Figures

FIGURE 1

FIGURE 1

Sarcopenia is associated with incident Alzheimer's dementia (AD). Risk of incident AD is higher in a participant with severe sarcopenia at baseline (red line, high composite sarcopenia score, 90th percentile) as compared to an individual with mild sarcopenia (black line, low composite sarcopenia score, 10th percentile)

References

    1. Cesari M, Kuchel GA. Role of sarcopenia definition and diagnosis in clinical care: moving from risk assessment to mechanism-guided interventions. J Am Geriatr Soc. 2020;68(7):1406–1409. - PubMed
    1. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. - PMC - PubMed
    1. Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc. 2020;68(7):1410–1418. - PMC - PubMed
    1. Ganmore I, Elkayam I, Ravona-Springer R, et al. Deterioration in motor function over time in older adults with type 2 diabetes is associated with accelerated cognitive decline. Endocr Pract. 2020;26 (10):1143–1152. - PubMed
    1. Yu L, Boyle PA, Leurgans SE, Wilson RS, Bennett DA, Buchman AS. Incident mobility disability, mild cognitive impairment, and mortality in community-dwelling older adults. Neuroepidemiology. 2019;53(1–2):55–62. - PMC - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources